Inhibition of IFN-γ-dependent antiviral airway epithelial defense by cigarette smoke
© The Author(s) 2010
Received: 21 December 2009
Accepted: 26 May 2010
Published: 26 May 2010
Although individuals exposed to cigarette smoke are more susceptible to respiratory infection, the effects of cigarette smoke on lung defense are incompletely understood. Because airway epithelial cell responses to type II interferon (IFN) are critical in regulation of defense against many respiratory viral infections, we hypothesized that cigarette smoke has inhibitory effects on IFN-γ-dependent antiviral mechanisms in epithelial cells in the airway.
Primary human tracheobronchial epithelial cells were first treated with cigarette smoke extract (CSE) followed by exposure to both CSE and IFN-γ. Epithelial cell cytotoxicity and IFN-γ-induced signaling, gene expression, and antiviral effects against respiratory syncytial virus (RSV) were tested without and with CSE exposure.
CSE inhibited IFN-γ-dependent gene expression in airway epithelial cells, and these effects were not due to cell loss or cytotoxicity. CSE markedly inhibited IFN-γ-induced Stat1 phosphorylation, indicating that CSE altered type II interferon signal transduction and providing a mechanism for CSE effects. A period of CSE exposure combined with an interval of epithelial cell exposure to both CSE and IFN-γ was required to inhibit IFN-γ-induced cell signaling. CSE also decreased the inhibitory effect of IFN-γ on RSV mRNA and protein expression, confirming effects on viral infection. CSE effects on IFN-γ-induced Stat1 activation, antiviral protein expression, and inhibition of RSV infection were decreased by glutathione augmentation of epithelial cells using N-acetylcysteine or glutathione monoethyl ester, providing one strategy to alter cigarette smoke effects.
The results indicate that CSE inhibits the antiviral effects of IFN-γ, thereby presenting one explanation for increased susceptibility to respiratory viral infection in individuals exposed to cigarette smoke.
A growing body of evidence indicates that cigarette smoke exposure increases susceptibility to viral (and bacterial) respiratory infection. It is well established that infants and children exposed to environmental tobacco smoke have an increased incidence and/or severity of otitis media and lower respiratory illness including respiratory syncytial virus (RSV) bronchiolitis compared to those not exposed [1–3]. Women passively exposed to cigarette smoke are at increased risk for more frequent common colds of longer duration . Similarly, individuals that actively smoke cigarettes have an increased incidence and longer duration of respiratory infection [4, 5]. Clinical upper respiratory infection is more common in smokers after controlled exposure to respiratory viruses . It has also been reported that healthy army recruits that smoke cigarettes had a higher attack rate and more severe infection during an H1N1 influenza epidemic . Thus, available information indicates that cigarette smoke increases the incidence, duration, and/or severity of respiratory viral infection. However, mechanisms responsible for the effects of cigarette smoke on lung defense are incompletely understood.
A central feature of the host response to viral infection in the airway is activation of epithelial cell genes that are important in innate and adaptive immunity by a potent group of mediators called interferons. Type II interferon (IFN) or IFN-γ is produced mainly by T cells and natural killer cells, and mediates host cell effects by binding to a specific receptor complex linked to a Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling cascade [8, 9]. Activation of the type II interferon-driven pathway is triggered by engagement and multimerization of the IFN-γ-receptor (IFNGR) by IFN-γ, phosphorylation of IFNGR1-associated Jak1 and IFNGR2-associated Jak2 tyrosine kinases, and then phosphorylation of IFNGR1 . Phosphorylation of the IFNGR1 chain of the IFN-γ receptor results in recruitment, phosphorylation, and subsequent release of Stat1 from the receptor . Activated Stat1 dimerizes, translocates to the nucleus, and binds IFN-γ-activated sequence (GAS) elements in IFN-γ-inducible genes where it works in concert with adjacent transcription factors (e.g., Sp1) and coactivators (e.g., CBP/p300) to increase gene transcription [12, 13]. IFN-γ-induced genes promote antiviral mechanisms that include leukocyte recruitment, antigen processing and presentation, cell proliferation and apoptosis, and antiviral state establishment.
Based on this information, we questioned whether cigarette smoke has direct effects on IFN-γ-dependent antiviral mechanism in airway epithelial cells that would impair host defense. In this report, we use primary human airway epithelial cells and an extract of cigarette smoke to demonstrate that this extract decreases antiviral effects of IFN-γ. These effects of cigarette smoke extract (CSE) are controlled, at least in part, through inhibition of Stat1 activation in epithelial cells. Furthermore, CSE effects on IFN-γ-dependent Stat1 activation and subsequent antiviral responses can be decreased by glutathione augmentation of epithelial cells suggesting that oxidants in cigarette smoke mediate a portion of these effects. Our results support the concept that exposure of the human airway to cigarette smoke directly impairs antiviral defense, thereby providing one explanation for increased respiratory virus susceptibility in individuals exposed to cigarette smoke.
Airway Epithelial Cell Isolation, Culture, and Treatments
Human trachea and bronchial samples from individuals without lung disease were obtained through the University of Iowa Cell Culture Core Repository under a protocol approved by the University of Iowa Institutional Review Board. Airways were dissected from lung tissue, and primary human tracheobronchial epithelial (hTBE) cells from the surface of airway mucosa were isolated by enzymatic dissociation. Cells were cultured in Laboratory of Human Carcinogenesis (LHC)-8e medium on plates coated with collagen/albumin as described previously [14, 15]. To assure reproducible and generalizable results, experiments were repeated at least 3 times using hTBE cells from different individuals. The 12 individuals that provided epithelial cells were 29-76 years of age and included current smokers, ex-smokers, and nonsmokers. Some samples were treated with 100 units/ml of recombinant human IFN-γ (a gift from Genentech, South San Francisco, CA). In some experiments, hTBE cells were treated with the antioxidants N-acetylcysteine (NAC) or glutathione monoethyl ester (GSH-MEE) from Sigma-Aldrich (St. Louis, MO), at concentration of 5 mM and 1 mM, respectively. Time course schematics are included above each experiment figure to clarify the order and duration of cell treatments.
Cigarette Smoke Extract
CSE was prepared by drawing mainstream smoke from the base of a lighted research reference cigarette (University of Kentucky) into a 60 ml syringe containing 10 ml of culture media. Smoke was drawn into the syringe 7 times with syringe capping and 100 shakes after each draw, resulting in combustion of the full length of the cigarette except for 0.5 cm adjacent to the filter. Consistency of the 100% CSE preparation was monitored by spectrophotometric measurement of absorbance, resulting in A300nm = 2.52-2.94 that correlated with an added cigarette smoke nonvolatile mass of 0.48-1.20 mg/ml. CSE was used immediately after generation, and was diluted to 5 or 10% in culture media (pH 7.24-7.35, normal media pH 7.25-7.30) prior to exposure of hTBE cells.
Whole cell and nuclear protein extract preparation and immunoblot analyses were performed as described previously [14, 19–22]. Primary antibodies used to detect specific cellular and nuclear proteins were: mouse IgG1 mAb clone 6 against human interferon regulatory factor-9 (IRF-9) from BD Transduction Laboratories (Lexington, KY); rabbit polyclonal IgG 4915 against human ICAM-1, rabbit polyclonal IgG 9172 against total human Stat1, and rabbit polyclonal IgG 9171 against tyrosine-701 phosphorylated human Stat1 from Cell Signaling Technology (Beverly, MA); rabbit polyclonal antiserum against human heat shock protein (HSP)-90 from Assay Designs (Ann Arbor, MI); mouse IgG2a mAb clone AC-74 against human β-actin from Sigma-Aldrich (St. Louis, MO); rabbit polyclonal IgG ab4742 against serine-727 phosphorylated human Stat1 from Abcam (Cambridge, MA); goat polyclonal IgG against human RSV proteins from Biodesign International (Saco, ME). Primary antibody binding was detected using donkey antigoat, goat antimouse, or goat antirabbit IgG conjugated to horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA) and an enhanced chemiluminescence detection system (Amersham Biosciences, Uppsala, Sweden). Reprobing of membranes was done after washing twice in Restore™ buffer (Pierce, Rockford, IL) for 15 minutes at 37°C. In most experiments, radiographic film images were analyzed using ImageJ software . To generate an integrated density level, band area was multiplied by the band mean gray value, and the integrated density for the protein of interest was divided by the corresponding β-actin level creating a ratio for each sample.
Epithelial Cytotoxicity Assays
Mitochondrial activity was assessed by quantification of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) reduction to a colored formazan product in the presence of phenazine ethosulfate using a commercial kit (Promega, Madison, WI). Determination of plasma membrane permeability to ethidium homodimers in dead cells and intracellular esterase activity in live cells was performed using a commercial fluorescence-based viability and cytotoxicity kit (Molecular Probes, Eugene, OR) as described previously [19, 20]. A positive control for 100% cell death was generated by adding the permeabilizing agent 1% saponin to cells.
High concentration human RSV strain A2 was from Advanced Biotechnologies (Columbia, MD), where it was produced from HEp-2 cell lysates. RSV was incubated with epithelial cells for 24 hours in culture media at 37°C in 5% CO2 at a multiplicity of infection (MOI) of 0.01 or 0.5 based on plaque titration assay using Vero cells as described previously [19, 20]. An MOI of 0.01 was used in experiments requiring viral mRNA detection and 0.5 was used in experiments detecting viral proteins. MOI levels were chosen that resulted in infection of only a small percentage of epithelial cells but gave easily detected viral molecule levels in order to allow quantification of an increase or decrease in infection.
Realtime Reverse Transcription PCR mRNA Analysis
Total cellular RNA was isolated using a commercial spin column isolation kit (Stratagene, La Jolla, CA), and equivalent amounts (0.5-1 μg) were reverse transcribed using a commercial kit (Ambion, Austin, TX). Equal aliquots of the resulting cDNA were subjected to PCR using an iCycler iQ Fluorescence Thermocycler (Bio-Rad Laboratories, Hercules, CA) with SYBR Green I DNA dye (Molecular Probes, Eugene, OR), iTaq™ DNA Polymerase (Bio-Rad Laboratories), and the following primers designed with software by S. Rozen and H. Skaletsky http://www.genome.wi.mit.edu/genome_software/other/primer3.html: 1) RSV N-gene sense 5'-GCTCTTAGCAAAGTCAAGTTGAATGA-3' and antisense 5'-TGCTCCGTTGGATGGTGTATT-3'; and 2) human hypoxanthine phosphoribosyltransferase (HPRT) sense 5'-GCAGACTTTGCTTTCCTTGG-3' and antisense 5'-AAGCAGATGGCCACAGAACT-3' or sense 5'-TTGGAAAGGGTGTTTATTCTTC-3' and antisense 5'-TCCCCTGTTGACTGGTCATT-3'. PCR conditions included denaturation at 95°C for 3 minutes, and then 45 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 30 s, followed by melting curve analysis. Fluorescence data was captured during annealing reactions, and specificity of the amplification was confirmed using melting curve analysis. Data was collected and recorded by iCycler iQ software (Bio-Rad Laboratories) and initially determined as a function of threshold cycle (Ct). Ct was defined as the cycle at which the fluorescence intensity in a given reaction tube rose above background, which was calculated as 10 times the mean standard deviation of fluorescence in all wells over the baseline cycles. Levels of mRNA are expressed relative to control HPRT levels, and calculated as 2ΔCt.
Epithelial cell reduced glutathione levels were determined using a commercial luminescence-based assay utilizing a reaction catalyzed by a glutathione S-transferase (Promega), and results were normalized to sample protein levels.
Enzyme-linked immunoassays, cytotoxicity and glutathione assays, realtime reverse transcription PCR mRNA analyses, and densitometry analyses were repeated multiple times to assure reproducible results and were analyzed for statistical significance using analysis of variance (ANOVA) for a factorial experimental design. The multicomparison significance level for the ANOVA was 0.05. If significance was achieved by one-way analysis, post-ANOVA comparison of means was performed using Bonferroni's or Tukey's tests .
Cigarette Smoke Extract Decreases Type II Interferon-Dependent Gene Expression
Cigarette Smoke Extract Causes Minimal Airway Epithelial Cell Cytotoxicity
Cigarette Smoke Extract Inhibits Type II interferon-Induced Stat1 Activation
Cigarette Smoke Extract Decreases Type II Interferon-Dependent Antiviral Defense
Glutathione Augmentation Inhibits Cigarette Smoke Extract Effects on Antiviral Defense
Cigarette smoke has been estimated to contain as many as 4,700 chemical compounds, including carbon monoxide, carbon dioxide, ammonia, methane, free radicals (e.g., superoxide and NO), and a variety of other highly reactive species such as aldehydes, semiquinones, and acrolein [31–33]. Cigarette smoke is conventionally described as having two phases: the tar phase (the > 1 μm particulate material trapped when smoke is passed through a standard Cambridge glass-fiber filter) and the gas phase (material that passes through the filter). The tar phase contains very high concentrations of radicals with the predominant species being the semiquinone radical, which is capable of reducing oxygen to superoxide and H2O2, and in the presence of free iron the highly reactive hydroxyl radical  The gas phase also contains various radical species, including NO and various carbon-based radicals, such as lipid peroxide radicals . Some specific components of cigarette smoke have already been shown to affect antiviral defense function. For example, acrolein has been shown to suppress IFN-α-mediated antiviral defense against hepatitis C virus in human hepatocytes and enhance RSV replication in human airway epithelial cells [37, 38]. Because cigarette smoke is a complex combination of many compounds that could affect epithelial cell functions in different ways, we felt it most valid to initially study the complete mixture in order to understand the overall effects of cigarette smoke on airway defense in humans.
Several models of cigarette smoke generation and cell exposure have been used in studies that assess biological effects. These vary from mixture of filtered or unfiltered cigarette smoke with media, solubilization of smoke material collected on a filter, direct cell exposure to cigarette smoke, as well as testing of individual components [37–41]. Each model has advantages and disadvantages that must be taken in to account when interpreting experimental results . The system used for our studies utilized cigarette smoke exposure prior to and during interferon treatment based on the concept that epithelial cells in the airway are likely exposed to smoke prior to respiratory viral infection. We also tested cells exposed to CSE for 48 hours prior to treatments, reasoning that humans are often passively or actively exposed to cigarette smoke for longer durations. Epithelial cell exposure to CSE during viral infection was avoided because cigarette smoke can directly affect viral infection and replication .
Our results indicate that cigarette smoke effects on epithelial cell glutathione levels are concentration-dependent. Decreased glutathione levels that were observed with cell exposure to 10% CSE correlate with results in other reports, and likely are due to an increased oxidant-antioxidant ratio that overwhelms the ability of the glutathione system to detoxify CSE reactive species [43, 44]. Conversely, many cigarette smokers have higher levels of GSH and this may correlate with our results using 5% CSE. Under these conditions, it is likely that low levels of cigarette smoke result in induction of the rate limiting enzyme in GSH synthesis, glutamate-cysteine ligase (formerly called γ-glutamylcysteine synthetase), through activation of the nuclear erythroid-related factor 2 (Nrf2) and AP-1 transcription factors [45, 46]. These results indicate that cigarette smoke effects may not be completely due to reactive oxygen species as we saw some inhibition of interferon effects with 5% CSE even though there were increased cellular glutathione levels. Furthermore, treatments that increased cellular glutathione levels generally resulted in incomplete although significant restoration of IFN-γ effects. We also found that a prolonged CSE exposure duration with a period of epithelial cell exposure to both CSE and IFN-γ was required to inhibit IFN-γ-induced cell signaling. This characteristic likely explains the lack of CSE effects on type II interferon signaling reported previously . This report also demonstrated that cigarette smoking condensate caused serine phosphorylation-dependent ubiquitination and degradation of the IFNAR1 subunit of the type I interferon receptor leading to attenuation of type I interferon antiviral responses in multiple cell lines. CSE requires time to activate an IFN-γ-modulating mechanism in order to affect this epithelial cell defense system, and we speculate that this is likely due to oxidant and nonoxidant-induced decreases in the level or activity of one or more type II interferon JAK-STAT signaling component (i.e., IFNGR1, IGNGR2, Jak1, and Jak2) or generation of a signaling inhibitor. Further studies are needed to determine the mechanisms for CSE effects on IFN-γ-induced Stat1 phosphorylation.
The results indicate that CSE directly inhibits antiviral effects of IFN-γ in epithelial cells through inhibition of the type II interferon JAK-STAT signaling cascade. However, other signaling pathways modulate IFN-γ-dependent responses, including p38 mitogen-activated protein (MAP) kinase, phosphatidylinositol 3 (PI3)-kinase, and protein kinase C isoforms [48–51]. Through alteration of these modulating pathways, CSE could indirectly affect IFN-γ-mediated immunity. Furthermore, there are multiple interferon pathways that control antiviral defense that could be affected by CSE. Recent reports indicate that type I interferon production, signal transduction, and antiviral effects are impaired in cells exposed to cigarette smoke condensate or conditioned media [47, 52, 53]. Altered interferon responses after cigarette smoke exposure may not be limited to epithelial cells. For example, macrophage and fibroblast cell lines exposed to cigarette smoke preparations in media and alveolar macrophages isolated from individuals that smoke cigarettes have reduced responsiveness to interferons [47, 52, 54–56]. Thus, cigarette smoke appears to affect multiple components of interferon-dependent antiviral defense. It is important to note that IFN-γ has other important functions in tissues besides antiviral defense. For example, IFN-γ is important for immune surveillance against malignant cells, and inhibition of interferon effects could be another mechanism through which cigarette smoke promotes lung carcinogenesis.
It appears that cigarette smoke has multiple effects that modify epithelial antiviral defense in the airway in addition to impairing interferon responses. Exposure to cigarette smoke leads to increased epithelial permeability both in vivo and in vitro, and this effect may amplify or mislocalize the airway defense response as well as allow viruses better access to their receptors on host cells [21, 41, 43, 57]. Smoking is also known to alter clearance of microbes from the lungs via direct and indirect effects on mucociliary clearance . Cigarette smoke has potent and widespread effects on both innate and adaptive immunity, including many effects on protease and inflammatory mediator levels released from epithelial cells in vitro and from lungs in vivo [39, 59–61]. For example, cigarette smoke inhibits the production of some cytokines while promoting the production of others . Specific components of cigarette smoke, such as NO2, ozone, and particulate matter, cause airway epithelial cell release of inflammatory mediators such as interleukin-8, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-α (TNF-α)[63, 64]. Cigarette smoke increased inflammation in mice infected with high levels of influenza . Furthermore, cigarette smoke has been shown to decrease pulmonary dendritic cells and antiviral immune responses in mice infected with adenoviral vectors . Taken together, these and likely other undefined effects of cigarette smoke on defense function in airway epithelia lead to increased viral infection and/or altered inflammation. In support of this possibility, cigarette smoke extract has been shown to induce cellular effects that increase RSV replication and inflammatory mediator expression in epithelial cells [38, 66]. Increased viral gene expression was also observed in neonatal mice exposed to cigarette smoke followed by infection with RSV . The importance of each cigarette smoke effect on and antiviral immunity and inflammation likely differs in each individual based on many variables that include number of and manner that cigarettes are smoked, presence of underlying lung disease, and difference in antioxidant levels and defense mechanism competence among individuals.
The results suggest that cigarette smoke alters type II interferon-dependent immunity in the airway resulting in increased incidence, duration, and/or severity or respiratory viral infections. A better understanding of mechanisms through which cigarette smoke impairs the host response to infection may allow for the development of therapeutic strategies that restore normal airway defense in individuals exposed to cigarette smoke.
The authors gratefully acknowledge the University of Iowa Cell Culture Core Repository and Genentech for generous gifts of cells or reagents, M. Haugsdal, B. Nardy, T. Nyunoya, and M. Wilson for technical assistance, and M. McCormick, G. Hunninghake, and D. Spitz for helpful discussion. This work was supported by Public Health Service grants HL082505 and HL075559 from the National Heart, Lung, and Blood Institute. The University of Iowa Cell Culture Core Repository is supported by grants from the National Institutes of Health and Cystic Fibrosis Foundation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.
- Gürkan F, Kiral A, Dagli E, Karakoç F: The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur J Epidemiol 2000, 16:465–468.View ArticlePubMedGoogle Scholar
- Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M: Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005, 115:e7-e14.PubMedGoogle Scholar
- U.S. Department of Health and Human Services: The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA; 2006.
- Benseñor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE, Manson JE: Active and passive smoking and risk of colds in women. Ann Epidemiol 2001, 11:225–231.View ArticlePubMedGoogle Scholar
- Blake GH, Abell TD, Stanley WG: Cigarette smoking and upper respiratory infection among recruits in basic combat training. Ann Intern Med 1988, 109:198–202.View ArticlePubMedGoogle Scholar
- Cohen S, Tyrrell DA, Russell MA, Jarvis MJ, Smith AP: Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health 1993, 83:1277–1283.View ArticlePubMedPubMed CentralGoogle Scholar
- Kark JD, Lebiush M, Rannon L: Cigarette smoking as a risk factor for epidemic A(H1N1) influenza in young men. N Engl J Med 1982, 307:1042–1046.View ArticlePubMedGoogle Scholar
- Bach EA, Aguet M, Schreiber RD: The IFN-g receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997, 15:563–591.View ArticlePubMedGoogle Scholar
- Taniguchi T, Takaoka A: A weak signal for strong responses: interferon-α/β revisited. Nature Reviews 2001, 2:378–386.View ArticlePubMedGoogle Scholar
- Bach EA, Tanner JW, Marsters S, Ashkenazi A, Aguet M, Shaw AS, Schreiber RD: Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol 1996, 16:3214–3221.View ArticlePubMedPubMed CentralGoogle Scholar
- Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD: Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 1995, 2:677–687.View ArticlePubMedGoogle Scholar
- Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ: Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 1995, 270:30264–30267.View ArticlePubMedGoogle Scholar
- Zhang JJ, Vinkemeier E, Gu W, Chakravarti D, Horvath CM, Darnell JE: Two contact regions between Stat1 and CBP/p300 in interferon g signaling. Proc Natl Acad Sci USA 1996, 93:15092–15096.View ArticlePubMedPubMed CentralGoogle Scholar
- Joseph TD, Look DC: Specific inhibition of interferon signal transduction pathways by adenoviral infection. J Biol Chem 2001, 276:47136–47142.View ArticlePubMedGoogle Scholar
- Aldallal N, McNaughton EE, Manzel LJ, Richards AM, Zabner J, Ferkol TW, Look DC: Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 2002, 166:1248–1256.View ArticlePubMedGoogle Scholar
- Look DC, Keller BT, Rapp SR, Holtzman MJ: Selective induction of intercellular adhesion molecule-1 by interferon-g in human airway epithelial cells. Am J Physiol 1992, 263:L79-L87.PubMedGoogle Scholar
- Frick AG, Joseph TD, Pang L, Rabe AM, St. Geme JW III, Look DC: Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells. J Immunol 2000, 164:4185–4196.View ArticlePubMedGoogle Scholar
- Chin CL, Manzel LJ, Lehman EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF, Sethi S, Look DC: Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 2005, 172:85–91.View ArticlePubMedPubMed CentralGoogle Scholar
- Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC: Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004, 30:893–900.View ArticlePubMedGoogle Scholar
- Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC: Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006, 344:328–339.View ArticlePubMedGoogle Scholar
- Humlicek AL, Manzel LJ, Chin CL, Shi L, Excoffon KJ, Winter MC, Shasby DM, Look DC: Paracellular permeability restricts airway epithelial responses to selectively allow activation by mediators at the basolateral surface. J Immunol 2007, 178:6395–6403.View ArticlePubMedGoogle Scholar
- Manzel LJ, Chin CL, Behlke MA, Look DC: Regulation of bacteria-induced intercellular adhesion molecule-1 by CCAAT/enhancer binding proteins. Am J Respir Cell Mol Biol 2009, 40:200–210.View ArticlePubMedGoogle Scholar
- Rasband WS: ImageJ. [http://rsb.info.nih.gov/ij/] National Institutes of Health, Bethesda, MD; 1997.
- Hassard TH: Understanding Biostatistics. St. Louis, MO: Mosby-Year Book, Inc; 1991.Google Scholar
- Veals SA, Schindler C, Leonard DB, Fu XY, Aebersold RH, Darnell JE, Levy DE: Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 1992, 12:3315–3324.View ArticlePubMedPubMed CentralGoogle Scholar
- Wong LH, Hatzinisiriou I, Devenish RJ, Ralph SJ: IFN-g priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs. J Immunol 1998, 160:5475–5484.PubMedGoogle Scholar
- Look DC, Pelletier MR, Holtzman MJ: Selective interaction of a subset of interferon-g response element binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem 1994, 269:8952–8958.PubMedGoogle Scholar
- Horvath CM, Darnell JE: The antiviral state induced by alpha and gamma interferon requires transcriptionally active Stat1 protein. J Virol 1996, 70:647–650.PubMedPubMed CentralGoogle Scholar
- Walter MJ, Look DC, Tidwell RM, Roswit WT, Holtzman MJ: Targeted inhibition of interferon-γ-dependent ICAM-1 expression using dominant-negative Stat1. J Biol Chem 1997, 272:28582–28589.View ArticlePubMedGoogle Scholar
- Boukhvalova MS, Prince GA, Blanco JCG: Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity. J Virol 2007, 81:9443–9450.View ArticlePubMedPubMed CentralGoogle Scholar
- Pryor WA, Prier DG, Church DF: Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 1983, 47:345–355.View ArticlePubMedPubMed CentralGoogle Scholar
- Pryor WA, Stone K: Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993, 686:12–28.View ArticlePubMedGoogle Scholar
- Eiserich JP, Vliet A, Handelman GJ, Halliwell B, Cross CE: Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995, 62:1490S-1500S.PubMedGoogle Scholar
- Rahman I, Biswas SK, Kode A: Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006, 533:222–239.View ArticlePubMedGoogle Scholar
- Zang LY, Stone K, Pryor WA: Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 1995, 19:161–167.View ArticlePubMedGoogle Scholar
- MacNee W: Oxidants/antioxidants and COPD. Chest 2000, 117:303S-317S.View ArticlePubMedGoogle Scholar
- Joshi-Barve S, Amancherla K, Patil M, Bhatnagar A, Mathews S, Gobejishvili L, Cave M, McClain C, Barve S: Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Free Radic Biol Med 2009, 47:47–54.View ArticlePubMedPubMed CentralGoogle Scholar
- Groskreutz DJ, Monick MM, Babor EC, Nyunoya T, Varga SM, Look DC, Hunninghake GW: Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol Biol 2009, 41:189–198.View ArticlePubMedPubMed CentralGoogle Scholar
- Hellermann GR, Nagy SB, Kong X, Lockey RF, Mohapatra SS: Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 2002, 3:22.View ArticlePubMedPubMed CentralGoogle Scholar
- Liu X, Togo S, Al-Mugotir M, Kim H, Fang Q, Kobayashi T, Wang X, Mao L, Bitterman P, Rennard S: NF-kappaB mediates the survival of human bronchial epithelial cells exposed to cigarette smoke extract. Respir Res 2008, 9:66.View ArticlePubMedPubMed CentralGoogle Scholar
- Petecchia L, Sabatini F, Varesio L, Camoirano A, Usai C, Pezzolo A, Rossi GA: Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway. Chest 2009, 135:1502–1512.View ArticlePubMedGoogle Scholar
- Shapiro SD: Smoke gets in your cells. Am J Respir Cell Mol Biol 2004, 31:481–482.View ArticlePubMedGoogle Scholar
- Morrison D, Rahman I, Lannan S, MacNee W: Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 1999, 159:473–479.View ArticlePubMedGoogle Scholar
- Rahman I, MacNee W: Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000, 28:1405–1420.View ArticlePubMedGoogle Scholar
- Rahman I, Smith CAD, Lawson MF, Harrison DJ, MacNee W: Induction of γ-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 1996, 396:21–25.View ArticlePubMedGoogle Scholar
- Knörr-Wittmann C, Hengstermann A, Gebel S, Alam J, Müller T: Characterization of Nrf2 activation and heme oxygenase-1 expression in NIH3T3 cells exposed to aqueous extracts of cigarette smoke. Free Radic Biol Med 2005, 39:1438–1448.View ArticlePubMedGoogle Scholar
- HuangFu WC, Liu J, Harty RN, Fuchs SY: Cigarette smoking products suppress anti-viral effects of type I interferon via phosphorylation-dependent downregulation of its receptor. FEBS Lett 2008, 582:3206–3210.View ArticlePubMedPubMed CentralGoogle Scholar
- Goh KC, Haque SJ, Williams BRG: p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 1999, 18:5601–5608.View ArticlePubMedPubMed CentralGoogle Scholar
- Nguyen H, Ramana CV, Bayes J, Stark GR: Roles of phosphatidylinositol 3-kinase in interferon-γ-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem 2001, 276:33361–33368.View ArticlePubMedGoogle Scholar
- Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A, Kambhampati S, Uddin S, Rahman A, Fish EN, Platanias LC: Activation of protein kinase Cδ by IFN-γ. J Immunol 2003, 171:267–273.View ArticlePubMedGoogle Scholar
- Chang Y, Holtzman MJ, Chen C: Differential role of janus family kinases (JAKs) in interferon-γ-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase cγ, c-Src, and STAT1. Mol Pharmacol 2004, 65:589–598.View ArticlePubMedGoogle Scholar
- Bauer CM, Dewitte-Orr SJ, Hornby KR, Zavitz CC, Lichty BD, Stämpfli MR, Mossman KL: Cigarette smoke suppresses type I interferon-mediated antiviral immunity in lung fibroblast and epithelial cells. J Interferon Cytokine Res 2008, 28:167–179.View ArticlePubMedGoogle Scholar
- Mian MF, Stämpfli MR, Mossman KL, Ashkar AA: Cigarette smoke attenuation of poly I:C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-beta production. Mol Immunol 2009, 46:821–829.View ArticlePubMedGoogle Scholar
- Braun KM, Cornish T, Valm A, Cundiff J, Pauly JL, Fan S: Immunotoxicology of cigarette smoke condensates: suppression of macrophage responsiveness to interferon gamma. Toxicol Appl Pharmacol 1998, 149:136–143.View ArticlePubMedGoogle Scholar
- Edwards K, Braun KM, Evans G, Sureka AO, Fan S: Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferon gamma. Hum Exp Toxicol 1999, 18:233–240.View ArticlePubMedGoogle Scholar
- Dhillon NK, Murphy WJ, Filla MB, Crespo AJ, Latham HA, O'Brien-Ladner A: Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers. Toxicol Appl Pharmacol 2009, 237:22–28.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang G, Zabner J, Deering C, Launspach J, Shao J, Bodner M, Jolly DJ, Davidson BL, McCray PBJ: Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo. Am J Respir Cell Mol Biol 2000, 22:129–138.View ArticlePubMedGoogle Scholar
- Drannik AG, Pouladi MA, Robbins CS, Goncharova SI, Kianpour S, Stämpfli MR: Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2004, 170:1164–1171.View ArticlePubMedGoogle Scholar
- Sopori M: Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2:372–377.View ArticlePubMedGoogle Scholar
- Robbins CS, Bauer CM, Vujicic N, Gaschler GJ, Lichty BD, Brown EG, Stämpfli MR: Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 2006, 174:1342–1351.View ArticlePubMedGoogle Scholar
- Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L, Anderson GP: Differential protease, innate immunity, and NF-κB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L931-L945.View ArticlePubMedGoogle Scholar
- Birrell MA, Wong S, Catley MC, Belvisi MG: Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 2007, 214:27–37.View ArticleGoogle Scholar
- Devalia JL, Campbell AM, Sapsford RJ, Rusznak C, Quint D, Godard P, Bousquet J, Davies RJ: Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993, 9:271–278.View ArticlePubMedGoogle Scholar
- Rusznak C, Devalia JL, Sapsford RJ, Davies RJ: Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur Respir J 1996, 9:2298–2305.View ArticlePubMedGoogle Scholar
- Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, Cox G, Stämpfli MR: Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004, 30:202–211.View ArticlePubMedGoogle Scholar
- Castro SM, Kolli D, Guerrero-Plata A, Garofalo RP, Casola A: Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation. Toxicol Sci 2008, 106:509–518.View ArticlePubMedPubMed CentralGoogle Scholar
- Phaybouth V, Wang SZ, Hutt JA, McDonald JD, Harrod KS, Barrett EG: Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model. Am J Physiol Lung Cell Mol Physiol 2006, 290:L222-L231.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.